Accessing Targeted Therapies: A Potential Roadblock to Implementing Precision Oncology?
Author(s) -
Mitchell S. von Itzstein,
Mary Lou Smith,
Elda Railey,
Carol White,
Julianne S. Dieterich,
Elizabeth GarrettMayer,
Suanna S. Bruinooge,
Andrew N. Freedman,
Janet S. de Moor,
Stacy W. Gray,
Jason Y. Park,
Jingsheng Yan,
Anh Quynh Hoang,
Hong Zhu,
David E. Gerber
Publication year - 2021
Publication title -
jco oncology practice
Language(s) - English
Resource type - Journals
eISSN - 2688-1535
pISSN - 2688-1527
DOI - 10.1200/op.20.00927
Subject(s) - medicine , food and drug administration , clinical trial , exact test , oncology , family medicine , pharmacology
Advances in genomic techniques have led to increased use of next-generation sequencing (NGS). We evaluated the extent to which these tests guide treatment decisions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom